Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
22%
OVERLAP
BY WEIGHT
26
# OF OVERLAPPING
HOLDINGS
BMED
137
HOLDINGS
23%
ALSO IN CANC
CANC
54
HOLDINGS
48%
ALSO IN BMED
SECTOR DRIFT (BMED minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BMED |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 3.3% | 3.1% | 3.1% |
|
MERCK & CO. INC. | 2.6% | 3.9% | 2.6% |
 |
NOVARTIS AG | 2.0% | 4.3% | 2.0% |
|
AMGEN INC | 1.6% | 2.2% | 1.6% |
|
ABBVIE INC | 1.5% | 2.9% | 1.5% |
BMED Overweight Relative to CANC
|
ROCHE HOLDING AG-BR | 3.4% |
 |
MEDTRONIC PLC | 3.2% |
|
EXACT SCIENCES CORP | 3.0% |
|
EDWARDS LIFESCIENCES CORP | 2.6% |
|
NATERA INC | 2.1% |
|
ABBOTT LABORATORIES | 2.0% |
|
INSULET CORP | 1.9% |
|
AGILENT TECHNOLOGIES INC | 1.9% |
|
GUARDANT HEALTH, INC. | 1.8% |
 |
GENMAB A/S | 1.8% |
BMED Underweight Relative to CANC
|
REVOLUTION MEDICINES, INC. | -5.5% |
|
ELI LILLY & CO | -5.3% |
 |
ASTRAZENECA PLC | -4.5% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -4.1% |
|
GENMAB A/S SPONSORED ADR | -3.7% |
|
BRIDGEBIO PHARMA, INC. | -3.3% |
|
COGENT BIOSCIENCES INC | -3.0% |
|
NUVALENT, INC. CLASS A | -2.6% |
|
BRISTOL-MYERS SQUIBB CO | -2.6% |
|
CELCUITY INC. | -2.4% |